Cargando…
DPYD, TYMS and MTHFR Genes Polymorphism Frequencies in a Series of Turkish Colorectal Cancer Patients
Fluoropyrimidine-based chemotherapy is extensively used for the treatment of solid cancers, including colorectal cancer. However, fluoropyrimidine-driven toxicities are a major problem in the management of the disease. The grade and type of the toxicities depend on demographic factors, but substanti...
Autores principales: | Amirfallah, Arsalan, Calibasi Kocal, Gizem, Unal, Olcun Umit, Ellidokuz, Hulya, Oztop, Ilhan, Basbinar, Yasemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313617/ https://www.ncbi.nlm.nih.gov/pubmed/30551678 http://dx.doi.org/10.3390/jpm8040045 |
Ejemplares similares
-
The Role of Cyanidin-3-O-glucoside in Modulating Oxaliplatin Resistance by Reversing Mesenchymal Phenotype in Colorectal Cancer
por: Kurter, Hasan, et al.
Publicado: (2023) -
An Efficient and Quick Analytical Method for the Quantification of an Algal Alkaloid Caulerpin Showed In-Vitro Anticancer Activity against Colorectal Cancer
por: Mert-Ozupek, Nazli, et al.
Publicado: (2022) -
In-silico molecular interactions among the secondary metabolites of Caulerpa spp. and colorectal cancer targets
por: Mert-Ozupek, Nazli, et al.
Publicado: (2022) -
PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1
por: Baskin, Yasemin, et al.
Publicado: (2016) -
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity
por: Loganayagam, A, et al.
Publicado: (2013)